Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone changes during prednisone treatment.

A Deding, L Tougaard, M Krogh Jensen

    Acta Medica Scandinavica
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [The diagnosis of "smoker's lung" encourages smoking cessation].

    Ugeskrift for laeger·1997
    Same author

    Effect of diagnosis of "smoker's lung". RYLUNG Group.

    Lancet (London, England)·1997
    Same author

    Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis.

    Scandinavian journal of clinical and laboratory investigation·1996
    Same author

    [Quality assurance of scintigraphic examinations of cerebral circulation. Presentation of a method].

    Ugeskrift for laeger·1995
    Same author

    [The osteoporosis profile--one more time].

    Ugeskrift for laeger·1995
    Same author

    [Osteoporosis profile--maybe a not so insignificant examination].

    Ugeskrift for laeger·1994
    Same journal

    On hereditary, non-hemolytic bilirubinemia.

    Acta medica Scandinavica·2010
    Same journal

    Infections with leukopenia treated with sulfa compounds.

    Acta medica Scandinavica·2010
    Same journal

    A peculiar conduction disturbance, persisting latently after recovery from complete heart block and disclosed only by electrocardiography following exercise.

    Acta medica Scandinavica·2010
    Same journal

    Titration with Weichbrodt's reagent of serum, particularly in the case of gall-liver diseases.

    Acta medica Scandinavica·2010
    Same journal

    Arthralgia due to nervous causes.

    Acta medica Scandinavica·2010
    Same journal

    Auricular standstill.

    Acta medica Scandinavica·2010
    See all related articles

    Corticosteroid treatment, specifically prednisone, significantly reduced bone mineral content (BMC) in patients over 12 weeks. Bone mineralization remained stable, suggesting equal loss of bone mineral and collagen, leading to osteoporosis.

    Area of Science:

    • Endocrinology
    • Bone Metabolism
    • Pharmacology

    Background:

    • Corticosteroids are widely used to treat inflammatory and autoimmune conditions.
    • Long-term corticosteroid use is associated with adverse effects on bone health.
    • Understanding the specific impact of corticosteroids on bone composition is crucial for patient management.

    Purpose of the Study:

    • To investigate the effects of prednisone treatment on bone composition.
    • To assess changes in bone mineral content (BMC) and the degree of bone mineralization.
    • To determine if prednisone dosage correlates with observed changes in bone.

    Main Methods:

    • Evaluated 18 patients receiving prednisone for hematological and connective tissue diseases.
    • Measured bone mineral content (BMC) using photon absorptiometry.

    Related Experiment Videos

  • Assessed bone mineralization degree via the bone phosphorus/hydroxyproline ratio over 12 weeks.

    • Main Results:

    • A significant decrease in BMC (mean 2.5%) was observed during 12 weeks of prednisone treatment.
    • No significant correlation was found between prednisone dose and BMC changes.
    • The degree of bone mineralization remained unchanged, indicating parallel losses of mineral and collagen.

    Conclusions:

    • Prednisone treatment leads to a rapid development of an osteoporotic state.
    • Bone loss during prednisone therapy involves both mineral and collagen components.
    • Further research is needed to mitigate corticosteroid-induced bone loss.